Placebo brownie

Phase 2

JJohns Hopkins University

Placebo brownie is one of 3 therapeutic programs targeting Cannabis Intoxication. It is currently in Phase 2.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[2][1]

Indication

Cannabis IntoxicationRecruiting

Cannabis IntoxicationPhase 2

Recruiting

Competition

Competitive Landscape

3 competitors in Cannabis Intoxication

#DrugCompanyPhaseTrials

Cannabis

TTO Pharmaceuticals

Phase 2

1 2

Pregnenolone

VVA Office of Research and Development

Phase 2

1 3

Placebo brownie

JJohns Hopkins University

Phase 2

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Q1 2029

Phase 2Recruiting

Cannabis Intoxication

NCT07216690

Clinical

Trials by Indication[1]

Cannabis Intoxication1 trial

Pregnenolone as a Treatment for Cannabis Intoxication

Recruiting·JJohns Hopkins University·Phase 2·NCT07216690·20 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for Placebo brownie. U.S. National Library of Medicine, National Institutes of Health.
[2]
Open Targets Platform — Drug–disease associations for Placebo brownie. EMBL-EBI & Wellcome Sanger Institute.
[3]
SEC EDGAR — Johns Hopkins University company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Highest Phase: Phase 2[1]
Company: JJohns Hopkins University

Placebo brownie

Status by Indication[2][1]

Competitive Landscape

Expected Milestones

Q1 2029

Trials by Indication[1]

Cannabis Intoxication1 trial

References

Drug Info

Quick Facts

Related News